Intellectual Property

Corporate

Intellectual Property

SureTouch™ is the only, FDA approved, tactile imaging device in the entire field of breast cancer detection. Given MTI’s unique technical expertise and strong intellectual property position, direct competition is nearly impossible.

MTI has secured all useful intellectual property rights for this field; there are no IP encumbrances. The tactile sensor technology that powers the SureTouch™ Pre-Mammogram System is exclusively licensed from Pressure Profile Systems, Inc. to Medical Tactile, Inc. for breast applications.This license also includes the key personnel to provide critical know-how in designing and fabricating the proprietary sensor, electronics and software. Key patents are listed below with other IP pending:

5,833,634	Tissue Examination
5,916,180	Calibrating Pressure Sensors
5,989,199	Tissue Examination - Array Algorithms
6,063,031	Diagnosis and Treatment of Tissue with Instruments
6,091,981	Clinical Tissue Examination
D425,980	Hand-Held Tissue Examination Device
6,179,790	Layer of Material for Use with Tissue Examination Device
6,500,119	Obtaining Images of Structures in Bodily Tissue
6,468,231	Self-Palpation Device for Examination of Breast
6,595,933	Self-Palpation Device with 3-D positioning System

Artann Laboratories has developed proprietary advanced tactile image enhancement, feature extraction, and 3D tactile imaging technology. MTI and Artann Laboratories have established a strategic partnership agreement where MTI has exclusive rights to all present and future IP created by Artann relating to the breast field.